% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • pharmaapproved pharmaapproved Jun 17, 2013 10:49 PM Flag

    Up to Date Analyst comments and PPS projestions, VERY INTERESTING

    6/11/2013 Piper Jaffray Reiterated Rating Arena Pharmaceuticals (ARNA) Overweight $9.00 $12.50
    Since Piper upgraded Arena, Lonnol Coats head of Eisia U.S. said recently that they see $150M Sales by the end of this year, That would put Pipers valuation at $20plus

    5/6/2013 Credit Suisse Lower Price Target Arena Pharmaceuticals (ARNA) $6.00 $5.00
    But wait as minute, Credit Suisse said last week "Credit Suisse estimates Belviq could crack the "blockbuster" mark of $1 billion in U.S. sales by 2018. Arena is also targeting a launch in South Korea next year, and Belviq is awaiting approval in several other countries" the oldest game in the book, tell everyone else to sell while we up our stake 451%.

    3/5/2013 JPMorgan Chase Lower Price Target Arena Pharmaceuticals (ARNA) $7.00
    But wait a minute. Cory Kasimov, an analyst with J.P. Morgan, he rated Arena as neutral recently. Arena was sitting in the mid $8's when this was quoted.

    2/6/2013 Leerink Swann Initiated Coverage Arena Pharmaceuticals (ARNA) Outperform $11.00 $12.00

    1/28/2013 TheStreet Reiterated Rating Arena Pharmaceuticals (ARNA) Sell
    Who cares what Jimbo thinks. I don't. (Youtube deep capture, Jimbo will tell you how they do it)

    11/7/2012 Jefferies Group Set Price Target Arena Pharmaceuticals (ARNA) Buy $14.00

    6/28/2012 Needham & Company Reiterated Rating Arena Pharmaceuticals (ARNA) Hold

    6/25/2012 BMO Capital Markets Arena Pharmaceuticals (ARNA) Market Perform $10.00


    Replace dot

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.26-0.13(-5.44%)Dec 1 4:00 PMEST